The research group led by Drs. Matsuda and Nakashima from the Graduate School of Medical Sciences, Kyushu University succeeded to convert neurons from mouse microglia by expression of a single transcription factor, NeuroD1.
Disruption of neuronal circuits by lesion such as stroke and spinal cord injury impairs neurotransmission and motor function. Reconstruction of disrupted neuronal circuits by provision of new neurons into lesion sites has been tested as a promising strategy to gain functional recovery from these nerve injuries. The research group focused on microglia which converge and accumulate at lesion sites for the clearance of dead cells as immune cells in the central nervous system after nerve injury, while they never differentiate into neurons physiologically. Here, the research group found that NeuroD1, known as an essential transcription factor for neuronal production in developing brain, converts microglia into induced neuronal (iN) cells accompanied by global remodeling of microglial epigenetic signature. Furthermore, iN cells were functionally integrated into brain circuits through synaptic connections with other neurons like endogenous neurons. These findings bring us one step closer to developing therapeutic strategies for nerve injury and disease by reprogramming microglia that accumulate at lesion sites into neurons.
This study was supported by JSPS KAKENHI (18K14820、16H06527) and the Platform Project for Supporting Drug Discovery and Life Science Research (BINDS) (JP16am0101102, JP16am0101103
and521, JP16am0101105). This work was published online in Neuron on Jan 10, 2019.
Schematic representation of this research
Fig. 2: Microglia (left) and iN cells (right). NeuroD1-transduced microglia exhibit neu-ronal morphology.